Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results
Article in Blood Advances (March 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
Article in Blood Advances (March 2024)
Article in Leukemia & Lymphoma (February 2023)
Article in American Journal of Clinical Pathology (March 2022)